FORMULATION DEVELOPMENT AND EVALUATION OF NIOSOMAL GEL OF COLLECTIVE ANTI-FUNGAL AGENTS
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i2.43484Keywords:
Tea tree oil, Eucalyptus oil, Niosome, Span 40, Span 60, Carbopol 934Abstract
Objectives: Tea tree oil (TTO) and Eucalyptus oil (EO) are essential oils derived from the leaves and terminal branches of Melaleuca alternifolia and Eucalyptus globulus. Both oils have narrative topical antifungal agents. Niosomal vesicles were chosen for Tea tree and EO dispersion in this investigation because of their ability to protect enclosed drugs, reduce drug dose amount, target drug delivery, increase residence time and penetration.
Methods: TTO and EO containing niosomes were made using a modified thin-film hydration process and Carbopol 934 as a gelling agent to produce a smooth antifungal niosomal gel.
Results: TTO and EO entrapment efficiency was found to be 84.89±0.19% and 86.86±0.57%, respectively, and percent cumulative drug diffusion of TTO and EO was found to be 84.21% and 85.22% in the prepared optimized batch [N9]. Transmission electron microscopy revealed vesicular, spherical particles in the nano range with a smooth surface. The optimum batch [N9] of niosomal gel was made with 1% w/w carbopol 934. TTO 84.9% and EO 86.89%, respectively, were found to have prolonged drug release in an in vitro release investigation utilizing the dialysis bag method. The G9 batch niosomal gel was found to be stable by performing an accelerated stability study for 3 months.
Conclusion: It was concluded that the best formulation batch G9 shows better-sustained release, enhanced residence time, and stability.
Downloads
References
Chidi F, Bouhoudan A, Khaddor M. Antifungal effect of the tea tree essential oil [Melaleuca alternifolia] against Penicillium griseofulvin and Penicillium verrucosum. J King Saud Univ Sci 2020;32 Suppl 3:2041-5.
Noumi E, Snoussi M, Hajlaoui H, Trabelsi N, Ksouri R, Valentin E, et al. Chemical composition, the antioxidant and antifungal potential of Melaleuca alternifolia [tea tree] and Eucalyptus globulus essential oils against oral Candida species. J Med Plants Res 2011;5 Suppl 17:4147-56.
Hayat U, Jilani MI, Rehman R, Nadeem F. A review on Eucalyptus globulus: A new perspective in therapeutics. Int J Chem Biochem Sci 2015;8:85-91.
Keshavshetti GG, Shirsand SB. Ciclopirox olamine-loaded niosomal gelas a topical drug delivery system for fungal. Pharm Reson 2019;2 Suppl 1:25-32.
Ahmed M. Topical gel formulation: A review. JPQA 2016;2 Suppl 1:1-10.
Alsarra IA. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul 2009;26 Suppl 3:272-8.
Patil PB, Datir SK, Saudagar RB. A review on topical gels as drug delivery system. J Drug Deliv Ther 2019;9 Suppl 3:989-94.
Ghanbarzadeh S, Khorrami A, Arami S. Nonionic surfactant-based vesicular system for transdermal drug delivery. Drug Deliv 2015;22 Suppl 8:1071-7.
More VV, Gilhotra RM, Nitalikar MM, Khule PK. Niosomal drug delivery-a comprehensive review. Asian J Pharm 2018;12 Suppl 4:S1159-64.
Akbari J, Saeedi M, Enayatifard R, Morteza-Semnani K, Hashemi SM, Babaei A, et al. Curcumin niosomes [curcusomes] as an alternative to conventional vehicles: A potential for efficient dermal delivery. J Drug Deliv Sci Technol 2020;60:1-10.
Abitha MH, Mathew F. Review article recent advances in topical gel formulation. World J Clin Pharmacol Micrbiol Toxicol 2015;1 Suppl 3:1-13.
Soni A, Society AE, Singla S. Review on novel approach in pharmaceutical gel. J Pharm Res 2019;8 Suppl 6:429-35.
Brown RA, Price C. Effect of surfactant concentration on core/ shell emulsion polymerization. Polym Commun Guildford 1989;30 Suppl 11:349-52.
Sankhyan A, Pawar P. Recent trends in niosome as vesicular drug delivery system. J Appl Pharm Sci 2012;2 Suppl 6:20-32.
Budhiraja A, Dhingra G. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv 2015;22 Suppl 6:723-30.
Mujoriya R, Bodla RB, Dhamande K, Singh D, Patle L. Niosomal drug delivery system: The magic bullet. J Appl Pharm Sci 2011;1 Suppl 9:20-3.
Muzzalupo R, Tavano L. Niosomal drug delivery for transdermal targeting: Recent advances. Res Rep Transdermal Drug Deliv 2015;4:23-33.
Kasar PM, Kale K, Phadtare DG. Formulation and evaluation of topical antifungal gel containing itraconazole. Int J Curr Pharm Res 2018;10 Suppl 4:71-4.
Wagh VD, Deshmukh OJ. Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans. ISRN Pharm 2012;2012:1-7.
Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 2010;11 Suppl 3:1119-27.
Desai U. Formulation and evaluation of niosomal in situ gel of prednisolone sodium phosphate for ocular drug delivery. Int J Appl Pharm 2019;11 Suppl 2:97-116.
Patil VA, Nitave SA. A review on Eucalyptus globulus: A divine medicinal herb. World J Pharm Pharm Sci 2014;3 Suppl 6:559-67.
Hammer KA, Carson CF, Riley TV. Antifungal activity of the components of Melaleuca alternifolia [tea tree] oil. J Appl Microbiol 2003;95 Suppl 4:853-60.
Paarakh MP, Jose PA, Setty CM, Peter GV. Release kinetics-concepts and applications. Int J Pharm Res Technol 2019;8 Suppl 1:12-20.
WHO. Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products. WHO Expert Comm Specif Pharm Prep Fifty-Second. Vol. 52. Geneva: WHO; 2018. p. 309-52.
Azeem A, Ahmad FJ, Khan ZI, Talegaonkar S. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol 2008;29 Suppl 5:723-30.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Vikrant Nikam
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
